Plasma homocysteine (Hcy) has been associated with an increased cardiovascular (CV) risk in patients with chronic heart failure (CHF). Thus, we investigated whether Hcy has a prognostic impact on CV events in CHF-patients with and without cardiorenal syndrome (CRS)
International audienceThe influence of hyperhomocysteinemia (HHCy) on cardiovascular disease (CVD) r...
Background: Hyperhomocysteinemia confers an increased risk of coronary artery disease, stroke, and d...
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.BackgroundWe prospect...
Elevated plasma homocysteine (HCY) is a known risk factor for atherosclerotic vascular disease and a...
PURPOSE: It is unclear whether plasma homocysteine (Hcy) has a direct noxious impact on the cardiova...
Background: Homocysteine is considered to be a risk factor, or an indicator of risk, for the develop...
SummaryObjectivesIt is unclear whether plasma homocysteine (Hcy) level affects long-term outcomes in...
Cardiovascular disease (CVD) is the leading cause of death worldwide. CVD is causally related to "cl...
Hyperhomocysteinemia is considered an independent risk factor for atherosclerosis in patients with n...
Elevated plasma levels of homocysteine is associated with increased risk of thrombotic and atheroscl...
Background—Although a raised plasma homocysteine is a risk factor for vascular disease, it is not kn...
peer reviewedHomocystinuria is an uncommon genetic disease characterized by a marked increase of ser...
Hyperhomocysteinemia is accompanied by many cardiovascular risk factors. However it’s relation with ...
International audienceHomocysteine (Hcy) is a sulfhydryl-containing amino acid, which is not acquire...
Elevated plasma levels of homocysteine is associated with increased risk of thrombotic and atheroscl...
International audienceThe influence of hyperhomocysteinemia (HHCy) on cardiovascular disease (CVD) r...
Background: Hyperhomocysteinemia confers an increased risk of coronary artery disease, stroke, and d...
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.BackgroundWe prospect...
Elevated plasma homocysteine (HCY) is a known risk factor for atherosclerotic vascular disease and a...
PURPOSE: It is unclear whether plasma homocysteine (Hcy) has a direct noxious impact on the cardiova...
Background: Homocysteine is considered to be a risk factor, or an indicator of risk, for the develop...
SummaryObjectivesIt is unclear whether plasma homocysteine (Hcy) level affects long-term outcomes in...
Cardiovascular disease (CVD) is the leading cause of death worldwide. CVD is causally related to "cl...
Hyperhomocysteinemia is considered an independent risk factor for atherosclerosis in patients with n...
Elevated plasma levels of homocysteine is associated with increased risk of thrombotic and atheroscl...
Background—Although a raised plasma homocysteine is a risk factor for vascular disease, it is not kn...
peer reviewedHomocystinuria is an uncommon genetic disease characterized by a marked increase of ser...
Hyperhomocysteinemia is accompanied by many cardiovascular risk factors. However it’s relation with ...
International audienceHomocysteine (Hcy) is a sulfhydryl-containing amino acid, which is not acquire...
Elevated plasma levels of homocysteine is associated with increased risk of thrombotic and atheroscl...
International audienceThe influence of hyperhomocysteinemia (HHCy) on cardiovascular disease (CVD) r...
Background: Hyperhomocysteinemia confers an increased risk of coronary artery disease, stroke, and d...
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.BackgroundWe prospect...